News

Rheumatology Advisor3h
Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis
For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.
Can Ozempic reverse liver disease? New study holds the answer
Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...
The Zacks Analyst Blog Highlights Novo Nordisk, Honeywell International and American Tower
Detailed price information for American Tower Corp (AMT-N) from The Globe and Mail including charting and trades.
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...
Health and Me on MSN11h
Ozempic Reverses Liver Diseases, New Study Finds
A new study published in the New England Journal Of Medicine claimed that it can tackle non-alcoholic steatohepatitis or NASH ...
Top Analyst Reports for Novo Nordisk, Honeywell & American Tower
Detailed price information for American Tower Corp (AMT-N) from The Globe and Mail including charting and trades.
Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra
Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...